This model of tumor intrinsic PD-L1 expression, which is dependent on oncogenetic tumor features, has been defined as constitutive to distinguish the so-called acquired expression, in which tumor cells express PD-L1 in response to IFN-γ expression mediated by antitumor lymphocyte activity (50). The gene discussed is IFNG; the disease is neoplasm.